Page 6 - Hpv Infections News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hpv infections. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hpv Infections Today - Breaking & Trending Today

Repertoire Immune Medicines and Dana-Farber Cancer Institute Collaborate to Identify Novel Antigen Targets Within HPV+ Head and Neck Cancers


Press release content from Business Wire. The AP news staff was not involved in its creation.
Repertoire Immune Medicines and Dana-Farber Cancer Institute Collaborate to Identify Novel Antigen Targets Within HPV+ Head and Neck Cancers
February 11, 2021 GMT
Anthony Coyle, Ph.D., President, Research and Development, Repertoire Immune Medicines (Photo: Business Wire)
CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 11, 2021
Repertoire Immune Medicines, a clinical-stage biotech company creating a new category of immune therapies for cancer, autoimmunity and infectious disease, today announced a research collaboration with Dana-Farber Cancer Institute to advance discovery and clinical development in human papillomavirus-positive (HPV+) oropharyngeal (head and neck) cancers. Through this collaboration, Dana-Farber and Repertoire aim to identify novel tumor antigen targets relevant to HPV+ head and neck tumors that will be used to inform the development of novel therapeutic cand ....

United Kingdom , Dana Farber Cancer Institute , United States , Ann Marie Egloff , Glenn Hanna , Carlo Tanzi , Lindsayg Deefholts , Sarah Nikiforow , Anthony Coyle , Ravindra Uppaluri , Department Of Surgery , Immune Medicines , Repertoire Immune Medicines , Business Wire , Rare Head , Neck Cancers , Neck Surgical Oncology , Lead Investigator , Medical Oncology , Study Identifier Number , Media Contact , Products And Services , Product Testing , Diagnosis And Treatment , Hpv Infections , Sexually Transmitted Diseases ,